We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
Cap. Flow
+$425M
Cap. Flow %
0.92%
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$128M
2
BKR icon
Baker Hughes
BKR
+$26.7M
3
IQV icon
IQVIA
IQV
+$14.5M
4
OKE icon
Oneok
OKE
+$14.3M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.2M

Sector Composition

Rank Sector Weight
1 Financials 16.64%
2 Technology 15.8%
3 Healthcare 13.57%
4 Industrials 10.87%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGBN icon
1476
Eagle Bancorp
EGBN
$846M
$2.47M 0.01%
36,863
+435
+1% +$27.3K
HTLD icon
1477
Heartland Express
HTLD
$948M
$2.47M 0.01%
98,535
+7,690
+8% +$167K
ASIX icon
1478
AdvanSix
ASIX
$541M
$2.47M 0.01%
62,095
-14,343
-19% -$487K
IVR icon
1479
Invesco Mortgage Capital
IVR
$759M
$2.47M 0.01%
14,395
+129
+0.9% +$21.7K
RARE icon
1480
Ultragenyx Pharmaceutical
RARE
$2.45B
$2.47M 0.01%
46,293
+889
+2% +$52.7K
GNCMA
1481
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$2.46M 0.01%
60,417
+783
+1% +$32K
IRWD icon
1482
Ironwood Pharmaceuticals
IRWD
$696M
$2.46M 0.01%
185,876
+1,793
+1% +$24.7K
TOWN icon
1483
Towne Bank
TOWN
$3.46B
$2.46M 0.01%
73,270
+410
+0.6% +$12.8K
JCP
1484
DELISTED
J.C. Penney Company, Inc.
JCP
$2.45M 0.01%
641,864
+12,055
+2% +$53.3K
SAFT icon
1485
Safety Insurance
SAFT
$1.52B
$2.44M 0.01%
31,985
+1,370
+4% +$97.5K
CFFN icon
1486
Capitol Federal Financial
CFFN
$1.09B
$2.44M 0.01%
165,943
+4,095
+3% +$57K
SPXC icon
1487
SPX Corp
SPXC
$11B
$2.44M 0.01%
82,984
+2,495
+3% +$65.6K
VTLE
1488
DELISTED
Vital Energy
VTLE
$2.44M 0.01%
9,415
+129
+1% +$31.2K
ECOL
1489
DELISTED
US Ecology, Inc.
ECOL
$2.43M 0.01%
45,239
+1,055
+2% +$53.6K
MATX icon
1490
Matsons
MATX
$6.13B
$2.43M 0.01%
86,316
+1,806
+2% +$50.4K
MDXG icon
1491
MiMedx Group
MDXG
$602M
$2.43M 0.01%
204,587
+6,045
+3% +$89.6K
BRKL
1492
DELISTED
Brookline Bancorp
BRKL
$2.43M 0.01%
156,730
+2,860
+2% +$41.5K
CHS
1493
DELISTED
Chicos FAS, Inc.
CHS
$2.42M 0.01%
270,702
-2,110
-0.8% -$18K
AVAV icon
1494
AeroVironment
AVAV
$7.56B
$2.42M 0.01%
44,738
+1,310
+3% +$55.8K
PLUS icon
1495
ePlus
PLUS
$2.42B
$2.42M 0.01%
52,368
+3,038
+6% +$124K
CHCO icon
1496
City Holding Co
CHCO
$2.05B
$2.4M 0.01%
33,364
+300
+0.9% +$19.5K
BRSL
1497
Brightstar Lottery PLC
BRSL
$1.84B
$2.4M 0.01%
97,671
+2,516
+3% +$51.4K
AAOI icon
1498
Applied Optoelectronics
AAOI
$7.57B
$2.4M 0.01%
37,039
+2,466
+7% +$174K
THC icon
1499
Tenet Healthcare
THC
$20.5B
$2.4M 0.01%
145,741
+5,163
+4% +$87.5K
TRNO icon
1500
Terreno Realty
TRNO
$7.57B
$2.4M 0.01%
66,189
+1,033
+2% +$36.3K

Similar funds

RhumbLine Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
  • RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
  • RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
  • RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
  • RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
  • RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.